These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7428046)

  • 1. Antigen-induced suppression of human in vitro pokeweed mitogen-stimulated antibody production.
    Stevens RH; Saxon A
    Cell Immunol; 1980 Sep; 55(1):85-93. PubMed ID: 7428046
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
    Stevens RH; Saxon A
    J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
    Kodo H; Gale RP; Saxon A
    J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of immunoglobulin and antigen-dependent antibody synthesis in human lymphocytes, using supernatants from mitogen-stimulated cultures.
    North ME; Brenner MK
    Immunology; 1983 Jan; 48(1):157-63. PubMed ID: 6600229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A restricted component of T cell help in pokeweed mitogen-stimulated humans peripheral blood cell cultures.
    Macy E; Stevens RH
    J Immunol; 1980 Feb; 124(2):752-9. PubMed ID: 6965390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization.
    Stevens RH; Macy E; Morrow C; Saxon A
    J Immunol; 1979 Jun; 122(6):2498-504. PubMed ID: 312871
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia.
    Yarchoan R; Schneider HS; Wray BB; Nelson DL
    J Clin Invest; 1983 Jun; 71(6):1720-7. PubMed ID: 6863541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of surface membrane IgG on pokeweed mitogen-reactive anti-tetanus toxoid antibody-producing cells.
    Thiele CJ; Stevens RH
    J Clin Immunol; 1981 Jul; 1(3):174-80. PubMed ID: 6801082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human IgA antibody and immunoglobulin production after in vivo tetanus toxoid immunization: size and surface membrane phenotype analysis.
    Thiele CJ; Morrow CD; Stevens RH
    J Clin Immunol; 1982 Oct; 2(4):327-34. PubMed ID: 7142369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro human antibody production to the Haemophilus influenzae type b capsular polysaccharide.
    Munoz JL; Insel RA
    J Immunol; 1987 Sep; 139(6):2026-31. PubMed ID: 3040862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple subsets of anti-tetanus toxoid antibody-producing cells in human peripheral blood differ by size, expression of membrane receptors, and mitogen reactivity.
    Thiele CJ; Morrow CD; Stevens RH
    J Immunol; 1981 Mar; 126(3):1146-53. PubMed ID: 6970218
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduced in vitro production of anti-tetanus toxoid antibody after repeated in vivo immunization with tetanus toxoid.
    Stevens RH; Saxon A
    J Immunol; 1979 Feb; 122(2):592-8. PubMed ID: 310845
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential synthesis of IgM and IgA anti-tetanus toxoid antibody in vitro following in vivo booster immunization of humans.
    Stevens RH; Saxon A
    Cell Immunol; 1979 Jun; 45(1):142-50. PubMed ID: 455480
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of pokeweed mitogen-driven human IgM and IgG responses by the hydroxylamine of sulfamethoxazole.
    Sisson ME; Rieder MJ; Bird IA; Almawi WY
    Int J Immunopharmacol; 1997 May; 19(5):299-304. PubMed ID: 9439768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization.
    Brogan MD; Shanahan F; Oliver M; Stevens RH; Targan SR
    J Clin Lab Immunol; 1987 Oct; 24(2):69-74. PubMed ID: 3437440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific in vivo and in vitro antibody response to tetanus toxoid immunization.
    Ershler WB; Moore AL; Hacker MP
    Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related decline in the in vitro and in vivo syntheses of anti-tetanus toxoid antibody in humans.
    Kishimoto S; Tomino S; Mitsuya H; Fujiwara H; Tsuda H
    J Immunol; 1980 Nov; 125(5):2347-52. PubMed ID: 6968781
    [No Abstract]   [Full Text] [Related]  

  • 18. IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells.
    Stevens R; Dichek D; Keld B; Heiner D
    J Clin Immunol; 1983 Jan; 3(1):65-9. PubMed ID: 6600745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired generation of spontaneous and mitogen-reactive antitetanus toxoid antibody-producing B cells following repetitive in vivo booster immunization.
    Saxon A; Tamaroff MA; Morrow C; Stevens RH
    Cell Immunol; 1981 Mar; 59(1):82-96. PubMed ID: 6971181
    [No Abstract]   [Full Text] [Related]  

  • 20. Dynamics of human circulating antigen reactive cells following secondary immunization with tetanus toxoid.
    Geha RS
    Clin Immunol Immunopathol; 1981 May; 19(2):196-205. PubMed ID: 6971719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.